Former SEC Commissioner and Yale Law Professor Try to Outflank SPACs
Last week, Pershing Square Tontine Holdings (NYSE: PSTH) was hit with a lawsuit from former SEC commissioner Robert Jackson and Yale law professor John Morley, claiming that PSTH violated the Investment Company Act of 1940. To which, Bill Ackman punched back by posting a letter to the PSTH website disputing the claims as well as proposing a solution for investors via his SPARC structure.
However, it appears that Jackson and Morley have decided to counter-punch by filing two more suits against GO Acquisition Corp. (NYSE: GOAC) and E.Merge Technology Acquisition Corp. (Nasdaq: ETAC), both claiming once again that the SPACs violated the Investment Company Act of 1940. This is despite law professors stating in the media that they thought this was an unlikely winnable strategy.
Interestingly, of the current 438 SPACs currently out searching for targets that they could have chosen to sue, Jackson and Morley have selected two more SPACs for litigation that have less than a year left on their clock. Specifically, 11.4 and 11.3 months, for GOAC and ETAC, respectively.
Furthermore, GOAC was underwritten by Credit Suisse, Citigroup and Morgan Stanley as joint-bookrunners, while ETAC was underwritten by Cantor Fitzgerald and Mizuho. All five of these banks (to a lesser extent Mizuho, being newer to the SPAC space) are powerhouses in underwriting SPAC deals.
If you’re going to pile on SPAC suits, these seem awfully convenient targets with convenient timelines, particularly if the strategy is to tie up higher-profile deals (with leading underwriters) in the court system. However, the additional suits do indicate that Jackson and Morley are not going to throw all their cards in with just Ackman. After all, Ackman is an activist investor and enjoys a good battle. Plus, he’s proven himself willing to fight endlessly to prove a point (see: Herbalife). Instead, the additional lawsuits appear to be a means to hedge their bets. You just need to win one case.
The question is, how will SPACs fight back?
Drugs Made in America Acquisition Corp. (NASDAQ:DMAAU) announced the pricing of its $200 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “DMAAU”, Tuesday, January 28, 2025. The new SPAC intends to combined with a target company in the pharmaceutical industry that has products derived from plant-based raw...
Black Spade II (NASDAQ:BSII) has entered into a definitive agreement to combine with World Media and Entertainment Universal at an equity value of $488 million. World Media is a bundle of assets including fashion publications and hotel properties held by AMTD Group and its subsidiaries. The combined company is expected to trade on a US...
Israel Acquisitions (NASDAQ:ISRL) has entered into a definitive agreement to combine with delivery drone developer Gadfin at an equity value of up to $200 million. Rehovot, Israel-based Gadfin has developed a line of cargo drones designed for medical and industrial applications. The combined company is expected to trade on the Nasdaq once the deal is...
Embrace Change (NASDAQ:EMCG) has entered into a definitive agreement to combine with tire manufacturer Tianji Global at a $450 million equity valuation. Jiaozuo, China-based Tianji manufactures vehicle tires that are distributed through about 200 sales outlets. The combined company is expected to trade on the Nasdaq once the deal is completed by mid-2025. Transaction Overview...
At the SPAC of Dawn Deals are back in SPACland as two business combinations were announced this morning. This not only triples the number of deals announced in 2025 to three, but it is also marks the first time multiple business combinations have been announced in one day since August 30, 2024. With that five...